prof. MUDr. Michael Doubek, Ph.D.
Head of the research group, Michael Doubek Research Group: Genetic predisposition to hematologic disorders Neuroscience
Correspondence Address:
Jihlavská 340/20, 625 00 Brno
Phone: | +420 532 23 2144, 3603 |
---|---|
E‑mail: |
social and academic networks: |
---|
Total number of publications: 867
2013
-
Ruxolitinib v léčbě primární myelofibrózy
Farmakoterapie, year: 2013, volume: Neuveden, edition: 2
-
Selected unquestionable oncologic diagnosis in case of flow cytometry application
Year: 2013, type: Conference abstract
-
SF3B1 mutations frequently occur with both ATM mutations and TP53 mutations in CLL patients
Year: 2013, type: Conference abstract
-
Significant antigens for detection of minimal residual disease in patients with mantle cell lymphoma using flow cytometry approach
Year: 2013, type: Conference abstract
-
The expression of a single microRNA -miR-34a - is a reliable marker for impairment of TP53-pathway in chronic lymphocytic leukemia
Year: 2013, type: Conference abstract
-
The expression of micrRNA-34a is a highly reliable for impairment of p53-pathway in CLL: development of clinically applicable assay
Year: 2013, type: Conference abstract
-
The origin of deletion 22q11 in chronic lymphocytic leukemia is related to the rearrangement of immunoglobulin lambda light chain locus
Leukemia Research, year: 2013, volume: 37, edition: 7, DOI
-
The outcome of chronic lymphocytic leukemia patients who relapsed after fludarabine, cyclophosphamide, and rituximab
European Journal of Haematology, year: 2013, volume: 90, edition: 6, DOI
-
The Planar Cell Polarity Pathway Drives Pathogenesis of Chronic Lymphocytic Leukemia by the Regulation of B-Lymphocyte Migration
Cancer Research, year: 2013, volume: 73, edition: 5, DOI
-
TP53 mutations associate with higher in vitro resistance of CLL cells to ofatumumab and rituximab
Year: 2013, type: Conference abstract